Healthcare & Insurance
Medication-Assisted Treatment in Clinical Trials: What to Expect
Medications for substance use disorders, like methadone for opioids or naltrexone for alcohol, can be an effective way to stave off cravings. During a clinical trial, researchers will track not just which medications are used but how they’re used and in what combination to get a better idea of what’s most effective for patients.
Here, we’ll look at how medication-assisted treatment (often called MAT, MOUD, or MAUD) works inside a clinical trial.
What Is Medication-Assisted Treatment?
Medication-assisted treatment refers to FDA-approved medications plus counseling or other support to treat a substance-use disorder. Common examples include:
- Methadone and buprenorphine for opioids
- Naltrexone, acamprosate, and disulfiram for alcohol.
It’s worth noting that there’s some overlap when it comes to MAT. For example, naltrexone may be used for both alcohol or Oxy addictions.
Medications can:
- Reduce cravings by blocking or changing the rewards pathways
- Lessen withdrawal symptoms
In a clinical trial, researchers might test new medications, new dosages, or new delivery pathways. They’ll also look at how additional emotional support, life family counseling, impacts the odds of relapse.
What Do MAT-Focused Trials Study?
Trials usually study:
- The best way to begin medication, especially for extremely risky behaviors (e.g., fentanyl use or heavy drinking)
- How long-acting injections compare against other tactics, like daily pills or clinic-based dosing
- How digital tools or contingency management improve medication adherence
- Patterns of use or side effects that point to who benefits most from different treatment methods
Clinical trials will usually target a specific demographic, such as people who are new to treatment or those who have tried medication and failed in the past.
What Participation Might Look Like
If you join a MAT-focused trial, you may:
- Detail your substance use history, medical conditions, and current medications.
- Complete blood work or other tests to ensure the medication is safe.
- Begin a new medication under close supervision and work with a professional to monitor its effects.
- Commit to supplementary non-medication support, like counseling sessions or group therapy. .
Trials may compare the side effects and dosages of two or more medications, or compare medication plus additional support (such as an app or financial incentive program) against medication alone.
Safety and Support
Addiction medications are extremely powerful, making safety central in these studies. Protections should include:
- Clear protocols for managing withdrawal, overdose risk, or side effects
- Emergency contact numbers and crisis procedures
- Regular reviews by safety boards and ethics committees
You should feel able to speak openly with the study team about your concerns, whether it’s an embarrassing side effect or a serious relapse.
Stigma and Myths About Medication Treatment
Using medications to treat addiction may sometimes spark negative backlash, and there are still plenty of people who believe that real recovery is a matter of mental strength. However, there’s an ever-growing body of quality research that shows, for many people, medications can:
- Reduce overdose deaths
- Improve retention in treatment
- Support long-term stability and functioning
While there’s still plenty of learn about the long-term effects of medication, including how best to match medications and how long to stick with them, that doesn’t cancel out the positive effects of medication treatments.
How to Decide if a MAT Trial Fits You
The biggest question about a MAT trial is whether you’re ready to try medication as a part of your recovery plan. Whether it’s a new medication, a new combination of a medication, or a return to an old medication under new supervision, you need to make a sincere commitment.
Additional questions for the trial operators include:
- Which medication or medications are part of this study, and why were they chosen?
- How will the trial coordinate with other care you may be receiving (such as primary care, mental health, or social services)?
- What is the long-term plan for medication after the study ends?
- How do the clinical trial operators plan to account for different types of patients (e.g., gender, size, etc.)?
- What type of support will you receive if you have severe side effects to the medication?
Starting a new round of medications can be intimidating, especially if you’re worried about how your body will adjust to the new regimen. It can help to get as many questions answered before starting the trial so you feel comfortable with how everything is run and what you can expect once it’s over.
The biggest hurdle for many patients is not what types of addiction-recovery medications are available, but whether they’re available at all. Many areas don’t offer this option, whether due to funding or philosophy. If you do have access to a clinical trial in your area, it may make sense to take advantage of the opportunity. Not only can it be an extremely effective treatment, but it can help scientists learn more about how to campaign for and expand access.